These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23865141)

  • 21. Nonalcoholic fatty liver disease and type 2 diabetes mellitus: the hidden epidemic.
    Ismail MH
    Am J Med Sci; 2011 Jun; 341(6):485-92. PubMed ID: 21412139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Nonalcoholic steatohepatitis--a "new" hepatic disease].
    Grønbaek H; Eivindson MV; Hamilton-Dutoit S; Vilstrup H
    Ugeskr Laeger; 2003 Mar; 165(11):1115-8. PubMed ID: 12677985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome.
    Boppidi H; Daram SR
    Postgrad Med; 2008 Jul; 120(2):E01-7. PubMed ID: 18654060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Albanian overweight children.
    Kodhelaj K; Resuli B; Petrela E; Malaj V; Jaze H
    Minerva Pediatr; 2014 Feb; 66(1):23-30. PubMed ID: 24608579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease.
    Tilg H; Moschen A
    Minerva Gastroenterol Dietol; 2010 Jun; 56(2):159-67. PubMed ID: 20485253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-alcoholic fatty liver disease: an emerging liver disease in Taiwan.
    Hsu CS; Kao JH
    J Formos Med Assoc; 2012 Oct; 111(10):527-35. PubMed ID: 23089687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD).
    Ali R; Cusi K
    Ann Med; 2009; 41(4):265-78. PubMed ID: 19353360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM
    Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonalcoholic fatty liver disease.
    Hjelkrem MC; Torres DM; Harrison SA
    Minerva Med; 2008 Dec; 99(6):583-93. PubMed ID: 19034256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patients: diagnosis and management.
    Lemoine M; Serfaty L; Capeau J
    Curr Opin Infect Dis; 2012 Feb; 25(1):10-6. PubMed ID: 22183113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonalcoholic fatty liver disease in Asia: a story of growth.
    Wong VW
    J Gastroenterol Hepatol; 2013 Jan; 28(1):18-23. PubMed ID: 23094755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?
    Amarapurkar DN; Hashimoto E; Lesmana LA; Sollano JD; Chen PJ; Goh KL;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):788-93. PubMed ID: 17565631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Non-alcoholic fatty liver disease in obese children and adolescents].
    Denzer C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Apr; 56(4):517-27. PubMed ID: 23529597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.
    Schuppan D; Schattenberg JM
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():68-76. PubMed ID: 23855299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Non alcoholic fatty liver disease assessment].
    Juriens I; Rigaux J; Blero D
    Rev Med Brux; 2012 Sep; 33(4):205-11. PubMed ID: 23091922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation and management of obesity-related nonalcoholic fatty liver disease.
    Nugent C; Younossi ZM
    Nat Clin Pract Gastroenterol Hepatol; 2007 Aug; 4(8):432-41. PubMed ID: 17667992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonalcoholic fatty liver disease.
    Yu AS; Keeffe EB
    Rev Gastroenterol Disord; 2002; 2(1):11-9. PubMed ID: 12122975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-alcoholic fatty liver disease and hepatitis C infection.
    Bondini S; Younossi ZM
    Minerva Gastroenterol Dietol; 2006 Jun; 52(2):135-43. PubMed ID: 16557185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology of non-alcoholic fatty liver disease.
    Bellentani S; Scaglioni F; Marino M; Bedogni G
    Dig Dis; 2010; 28(1):155-61. PubMed ID: 20460905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Non-alcoholic fatty liver disease in children: a new complication of obesity].
    Bocca G; Stolk RP; Scheenstra R; Sauer PJ
    Ned Tijdschr Geneeskd; 2008 Nov; 152(45):2443-7. PubMed ID: 19051794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.